NCT07562581 A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC Status NOT_YET_RECRUITING Phase PHASE2
NCT06884839 Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis Status COMPLETED Phase N/A
NCT06863272 A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02) Status RECRUITING Phase PHASE1/PHASE2
NCT03644303 Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients. Status COMPLETED Phase NA